Back to SYRE

FRANKLIN TEMPLETON INC → SYRE

FRANKLIN TEMPLETON INC SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
12
Latest value
$17.8M
Q3 2026
Peak value
$95.3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$2K
Q4 2025$36.3M
Q1 2026$3K
Q1 2026$44.5M
Q2 2026$5K
Q2 2026$90.6M
Q2 2026$25M
Q2 2026$15.1M
Q3 2026$8K
Q3 2026$95.3M
Q3 2026$29.1M
Q3 2026$17.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$17.8M180.1K——
Q3 2026$29.1M293.7K——
Q3 2026$95.3M961.9K——
Q3 2026$8K85——
Q2 2026$15.1M170.6K——
Q2 2026$25M281.3K——
Q2 2026$90.6M1.02M——
Q2 2026$5K55——
Q1 2026$44.5M882.8K——
Q1 2026$3K55——
Q4 2025$36.3M1.11M——
Q4 2025$2K47——

Other funds holding SYRE

Other FRANKLIN TEMPLETON INC positions

MSFT

MICROSOFT CORP

$10.1B
AAPL

APPLE INC

$9.6B
MSFT

MICROSOFT CORP

$9.3B
NVDA

NVIDIA CORPORATION

$9.2B
NVDA

NVIDIA CORPORATION

$9B
NVDA

NVIDIA CORPORATION

$8.7B
NVDA

NVIDIA CORPORATION

$8.4B
MSFT

MICROSOFT CORP

$7.9B